IP Library Granted Patent US 8,440,419
Granted Patent B2
US 8,440,419 · App. 12/682,240 · Granted May 14, 2013

Method and kit for quantitatively determining small, dense LDL cholesterol

Inventors: Yasuki Itoh (Niigata, JP); Miki Fujimura (Niigata, JP)
Assignee: Denka Seiken Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,440,419
App. No.
12/682,240
Granted
May 14, 2013
Kind
B2
Abstract

A method for fractional measurement of small, dense LDL, which is adaptable for an autoanalyzer, and a reagent for measurement, are provided, making it possible to conduct rapid and convenient analysis with good sensitivity without pretreatment of a specimen. The method for quantitatively determining small, dense LDL cholesterol in a sample comprises the steps of: (1) eliminating cholesterol in LDL other than small, dense LDL in the presence of phospholipase; and (2) quantitatively determining cholesterol in lipoproteins remaining in step (1) above.

Claims (15)

1. A method for quantitatively determining small, dense low density lipoprotein (LDL) cholesterol in a sample, comprising the steps of:

(1) eliminating cholesterol in LDL other than small, dense LDL in the presence of a phospholipase that has high reactivity with at least sphingomyelin and/or phosphatidylinositol, which is a phospholipid existing in lipoproteins, and then

(2) quantitatively determining cholesterol in the remaining small, dense LDL.

2. The method for quantitatively determining small, dense LDL cholesterol according to claim 1 , wherein the concentration of phospholipase to be used in step (1) ranges from 0.1 U/mL to 100 U/mL.

3. The method for quantitatively determining small, dense LDL cholesterol according to claim 1 , wherein an enzyme for cholesterol measurement is added in the presence of a surfactant that acts on at least small, dense LDL in step (2).

4. The method for quantitatively determining small, dense LDL cholesterol according to claim 3 , wherein the surfactant that acts on at least small, dense LDL, which is used in step (2), is a surfactant that acts on all lipoproteins.

5. The method for quantitatively determining small, dense low density lipoprotein (LDL) cholesterol according to claim 3 , wherein the surfactant that acts on at least small, dense LDL, which is used in step (2), is a polyoxyethylene-polyoxypropylene copolymer or a derivative thereof, or a polyoxyethylene derivative with hydrophile-lipophile (HLB) of 11 or more and less than 14.

6. The method for quantitatively determining small, dense LDL cholesterol according to claim 1 , further comprising step (a) of eliminating cholesterol in lipoproteins other than LDL in a sample in the presence of cholesterol esterase, which is carried out before step (2), but simultaneously with, before, or after step (1).

7. The method for quantitatively determining small, dense LDL cholesterol according to claim 6 , wherein the concentration of cholesterol esterase to be used in step (a) ranges from 0.01 U/mL to 10 U/mL.

8. The method for quantitatively determining small, dense LDL cholesterol according to claim 6 , wherein a surfactant that acts on lipoproteins other than LDL is further added in step (a).

9. The method for quantitatively determining small, dense low density lipoprotein (LDL) cholesterol according to claim 8 , wherein the concentration of the surfactant to be used in step (a) ranges from 0.05% (w/v) to 1.0% (w/v).

10. The method for quantitatively determining small, dense LDL cholesterol according to claim 6 , wherein cholesterol oxidase and catalase are further added in step (a).

11. The method for quantitatively determining small, dense LDL cholesterol according to claim 6 , wherein cholesterol oxidase and 4 aminoantipyrine are further added in step (a).

12. The method for quantitatively determining small, dense LDL cholesterol according to claim 6 , wherein the reaction in step (a) and the reaction in step (1) are conducted simultaneously in the same solution.

13. The method for quantitatively determining small, dense LDL cholesterol according to claim 6 , wherein the surfactant to be used in step (a) is a nonionic surfactant selected from the group consisting of a polyoxyethylene derivative, polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether, and polyoxyethylene alkyl amine, an anionic surfactant selected from the group consisting of polyoxyethylene alkyl ether sulfate, alkyl sulfate, amide ether sulfate, alkyl taurate, and a phosphate-type surfactant, a cationic surfactant selected from the group consisting of an alkyl methyl ammonium salt, a quaternary ammonium salt, and a mono-linear alkyl type surfactant, or an amphoteric surfactant selected from the group consisting of lauryl betaine, dimethyl alkyl betaine, an imidazoline type surfactant, and sodium alkyldiaminoethyl glycine.

Assignments (2)
MERGER Recorded Oct 5, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 053976/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2010
From: ITOH, YASUKI; FUJIMURA, MIKI
To: DENKA SEIKEN CO., LTD.
Reel/Frame 024207/0864 →
Priority Claims (1)
JP 2007-264908 · Oct 10, 2007 · national
Continuity (1)
Related Publication 20100255516A1 · Oct 7, 2010